The Journal of Experimental Medicine
ReproCELL
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online June 4, 2007
doi:10.1084/jem.20070325
The Journal of Experimental Medicine, Vol. 204, No. 6, 1487-1501
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Nolte et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 5225K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nolte, M. A.
Right arrow Articles by Sousa, C. R. e
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nolte, M. A.
Right arrow Articles by Sousa, C. R. e
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo

Martijn A. Nolte, Salomé LeibundGut-Landmann, Olivier Joffre, and Caetano Reis e Sousa

Immunobiology Laboratory, Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, London WC2A 3PX, England, UK

CORRESPONDENCE Caetano Reis e Sousa: caetano{at}cancer.org.uk

Dendritic cell (DC) activation is a prerequisite for T cell priming. During infection, activation can ensue from signaling via pattern-recognition receptors after contact with pathogens or infected cells. Alternatively, it has been proposed that DCs can be activated indirectly by signals produced by infected tissues. To address the contribution of tissue-derived signals, we measured DC activation in a model in which radioresistant cells can or cannot respond to lipopolysaccharide (LPS). We report that recognition of LPS by the radioresistant compartment is sufficient to induce local and systemic inflammation characterized by high circulating levels of tumor necrosis factor (TNF) {alpha}, interleukin (IL) 1ß, IL-6, and CC chemokine ligand 2. However, this is not sufficient to activate DCs, whether measured by migration, gene expression, phenotypic, or functional criteria, or to render DC refractory to subsequent stimulation with CpG-containing DNA. Similarly, acute or chronic exposure to proinflammatory cytokines such as TNF-{alpha} ± interferon {alpha}/ß has marginal effects on DC phenotype in vivo when compared with LPS. In addition, DC activation and migration induced by LPS is unimpaired when radioresistant cells cannot respond to the stimulus. Thus, inflammatory mediators originating from nonhematopoietic tissues and from radioresistant hematopoietic cells are neither sufficient nor required for DC activation in vivo.


Abbreviations used: ARE, AU-rich elements; CCL, CC chemokine ligand; CCR, CC chemokine receptor; CXCL, CXC chemokine ligand; GeoMFI, geometric mean fluorescence intensity; PALS, periarteriolar lymphatic sheath; PAMP, pathogen-associated molecular pattern; PRR, pattern-recognition receptor; SOCS, suppressor of cytokine signaling; TLR, Toll-like receptor.

M.A. Nolte's present address is Dept. of Experimental Immunology, Academic Medical Centre, 1105 AZ Amsterdam, Netherlands.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS